Cellular Genome-Scale Metabolic Modeling Identifies New Potential Drug Targets Against Hepatocellular Carcinoma
- 1 December 2022
- journal article
- research article
- Published by Mary Ann Liebert Inc in OMICS: A Journal of Integrative Biology
- Vol. 26 (12), 671-682
- https://doi.org/10.1089/omi.2022.0122
Abstract
Genome-scale metabolic modeling (GEM) is one of the key approaches to unpack cancer metabolism and for discovery of new drug targets. In this study, we report the Transcriptional Regulated Flux Balance Analysis-CORE (TRFBA-), an algorithm for GEM using key growth-correlated reactions using hepatocellular carcinoma (HCC), an important global health burden, as a case study. We generated a HepG2 cell-specific GEM by integrating this cell line transcriptomic data with a generic human metabolic model to forecast potential drug targets for HCC. A total of 108 essential genes for growth were predicted by the TRFBA-CORE. These genes were enriched for metabolic pathways involved in cholesterol, sterol, and steroid biosynthesis. Furthermore, we silenced a predicted essential gene, 11-beta dehydrogenase hydroxysteroid type 2 (HSD11B2), in HepG2 cells resulting in a reduction in cell viability. To further identify novel potential drug targets in HCC, we examined the effect of nine drugs targeting the essential genes, and observed that most drugs inhibited the growth of HepG2 cells. Some of these drugs in this model performed better than Sorafenib, the first-line therapeutic against HCC. A HepG2 cell-specific GEM highlights sterol metabolism to be essential for cell growth. HSD11B2 downregulation results in lower cell growth. Most of the compounds, selected by drug repurposing approach, show a significant inhibitory effect on cell growth in a wide range of concentrations. These findings offer new molecular leads for drug discovery for hepatic cancer while also illustrating the importance of GEM and drug repurposing in cancer therapeutics innovation.Keywords
This publication has 84 references indexed in Scilit:
- Reconstruction of genome-scale metabolic models for 126 human tissues using mCADREBMC Systems Biology, 2012
- Metabolite Profiling Identifies a Key Role for Glycine in Rapid Cancer Cell ProliferationScience, 2012
- Predicting selective drug targets in cancer through metabolic networksMolecular Systems Biology, 2011
- Single agent and combination studies of pralatrexate and molecular correlates of sensitivityBritish Journal of Cancer, 2010
- Metabolic genes in cancer: Their roles in tumor progression and clinical implicationsBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2010
- Computational reconstruction of tissue‐specific metabolic models: application to human liver metabolismMolecular Systems Biology, 2010
- Context-Specific Metabolic Networks Are Consistent with ExperimentsPLoS Computational Biology, 2008
- Global reconstruction of the human metabolic network based on genomic and bibliomic dataProceedings of the National Academy of Sciences of the United States of America, 2007
- Gene Expression Omnibus: NCBI gene expression and hybridization array data repositoryNucleic Acids Research, 2002
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001